Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
ICD-10 N03.5 is a billable code used to indicate a diagnosis of chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis.
Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis is characterized by persistent inflammation of the glomeruli, leading to a combination of nephritic and nephrotic features. Patients typically present with symptoms such as hematuria, proteinuria, and hypertension. The diffuse mesangiocapillary glomerulonephritis is marked by an increase in mesangial cells and matrix, resulting in a thickened glomerular capillary wall. This condition can lead to progressive renal impairment and is often associated with systemic diseases such as lupus or infections. Diagnosis is confirmed through renal biopsy, which reveals mesangial proliferation and capillary wall changes. Management involves controlling blood pressure, reducing proteinuria, and addressing any underlying conditions. Immunosuppressive therapy may be indicated in cases with significant renal impairment or persistent nephrotic syndrome.
Detailed clinical notes on symptoms, lab results, and treatment plans.
Patients presenting with hematuria, proteinuria, and hypertension.
Ensure renal biopsy results are clearly documented and correlate with clinical findings.
Comprehensive reports on renal biopsy histology and immunofluorescence findings.
Evaluation of renal tissue for glomerular diseases.
Accurate description of mesangial proliferation and capillary changes is crucial.
When a renal biopsy is performed to confirm diagnosis.
Document indication for biopsy, findings, and any complications.
Nephrologists must ensure biopsy results are correlated with clinical symptoms.
Key symptoms include hematuria, proteinuria, hypertension, and renal impairment.
Diagnosis is typically made through renal biopsy, which reveals characteristic histological changes.
